000 01297 a2200337 4500
005 20250515233205.0
264 0 _c20110314
008 201103s 0 0 eng d
022 _a1365-2036
024 7 _a10.1111/j.1365-2036.2010.04414.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSingal, A K
245 0 0 _aMeta-analysis: interferon improves outcomes following ablation or resection of hepatocellular carcinoma.
_h[electronic resource]
260 _bAlimentary pharmacology & therapeutics
_cOct 2010
300 _a851-8 p.
_bdigital
500 _aPublication Type: Journal Article; Meta-Analysis; Review; Systematic Review
650 0 4 _aAntiviral Agents
_xtherapeutic use
650 0 4 _aCarcinoma, Hepatocellular
_xdrug therapy
650 0 4 _aHepatectomy
650 0 4 _aHepatitis C, Chronic
_xcomplications
650 0 4 _aHumans
650 0 4 _aInterferons
_xtherapeutic use
650 0 4 _aLiver Cirrhosis
_xcomplications
650 0 4 _aLiver Neoplasms
_xdrug therapy
650 0 4 _aSecondary Prevention
650 0 4 _aTreatment Outcome
700 1 _aFreeman, D H
700 1 _aAnand, B S
773 0 _tAlimentary pharmacology & therapeutics
_gvol. 32
_gno. 7
_gp. 851-8
856 4 0 _uhttps://doi.org/10.1111/j.1365-2036.2010.04414.x
_zAvailable from publisher's website
999 _c19999474
_d19999474